The Trigger Tool as a Method to Measure Harmful Medication Errors in Children

Jolanda M Maaskant, Marian Smeulers1, Diederik Bosman

  • 1Department of Quality Assurance and Process Innovation, and.

Insights

A pediatric medication-focused trigger tool failed to detect harmful medication errors (MEs) in children. A multifaceted method is more effective for identifying unsafe situations and improving medication safety.

Area of Science:

  • Pediatric Patient Safety
  • Medication Error Detection
  • Healthcare Quality Improvement

Background:

  • Medication errors (MEs) pose a significant risk to pediatric patient safety.
  • Quantifying preventable MEs is crucial for improving care.
  • Trigger tools are proposed as efficient methods for ME detection, but their performance needs evaluation.

Purpose of the Study:

  • To evaluate the performance of a pediatric medication-focused trigger tool in identifying harmful medication errors.
  • To compare the effectiveness of a trigger tool against a multifaceted method for ME detection.

Main Methods:

  • A multifaceted method was established as the reference standard for detecting harmful MEs.
  • A pediatric medication-focused trigger tool was compared against the multifaceted method in a cohort of 369 pediatric patients.
  • Data collection was conducted by separate, blinded teams to ensure objectivity.

Main Results:

  • The multifaceted method identified 33 harmful MEs.
  • The original trigger tool failed to detect any harmful MEs.
  • An extended trigger tool, including pain and nausea/vomiting symptoms, identified 19 harmful MEs, with a sensitivity of 21.2% and a positive predictive value of 36.8%.

Conclusions:

  • The original pediatric medication-focused trigger tool was ineffective in detecting harmful MEs and identifying unsafe situations.
  • A multifaceted method remains the preferred approach for detecting harmful medication errors in pediatric patients.
  • The added value of the evaluated trigger tool for improving medication safety is uncertain.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
101
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
567
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
319
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K